Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Biodesix, Inc. (BDSX) had Normalized Pre-Tax Income of $-7.27M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
$26.86M |
|
$-7.27M |
|
$4.82M |
|
$22.04M |
|
$32.25M |
|
$-5.39M |
|
$-1.89M |
|
$-7.27M |
|
|
Normalized Pre-Tax Income |
$-7.27M |
$-7.27M |
|
$-7.27M |
|
$-7.27M |
|
$-7.27M |
|
$-5.39M |
|
$-3.64M |
|
10.30M |
|
10.30M |
|
$-0.71 |
|
$-0.71 |
|
| Balance Sheet Financials | |
$43.56M |
|
$23.80M |
|
$51.76M |
|
$95.33M |
|
$15.29M |
|
$46.82M |
|
$70.89M |
|
$86.18M |
|
$9.14M |
|
$-8.87M |
|
$9.14M |
|
10.55M |
|
| Cash Flow Statement Financials | |
$-11.73M |
|
$-0.40M |
|
$23.14M |
|
$19.07M |
|
$30.08M |
|
$11.01M |
|
$1.94M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.85 |
|
-- |
|
-- |
|
0.84 |
|
5.12 |
|
82.06% |
|
-20.06% |
|
-20.06% |
|
-- |
|
-27.08% |
|
-27.08% |
|
$-12.01M |
|
-- |
|
-- |
|
-- |
|
0.28 |
|
-- |
|
2.95 |
|
30.53 |
|
-79.54% |
|
82.03% |
|
-7.63% |
|
-13.00% |
|
$0.87 |
|
$-1.17 |
|
$-1.14 |
|